Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q1 2019 · 10-Q
Revenue$45.00K$45.00K−63.1% vs Q1 2018 Net Income-$4.40M-$4.40MN/M vs Q1 2018 EPS Diluted-$0.25-$0.25N/M vs Q1 2018 Operating Income-$3,950,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,052,000N/M Margins · derivedOperating margin-8777.8%−6022.9 pt vs Q1 2018
Net margin-9773.3%−6637.3 pt vs Q1 2018
ended Sep 30, 2018 · filed Nov 13, 2018 · 44 d after period end